Literature DB >> 16857507

Posterior capsule opacification after cataract surgery in patients with diabetes mellitus.

Yoko Ebihara1, Satoshi Kato, Tetsuro Oshika, Mayumi Yoshizaki, Gentaro Sugita.   

Abstract

PURPOSE: To prospectively compare the degree of posterior capsule opacification (PCO) after cataract surgery in patients with and without diabetes mellitus.
SETTING: Sugita Eye Hospital, Nagoya, Japan.
METHODS: Forty-two eyes of 42 consecutive diabetes mellitus patients (DM group) and 42 eyes of 42 non-DM patients (control group) scheduled to have cataract surgery were enrolled. The PCO value was determined using the posterior capsule opacification (POCO) system 3, 6, and 12 months after surgery.
RESULTS: Posterior capsule opacification values 3 months after surgery did not differ significantly between the 2 groups (P>.05). At 6 and 12 months, the PCO values of the DM group were significantly higher than those of the control group (P = .002 and P = .03, respectively).
CONCLUSION: Diabetic patients had significantly more severe PCO after cataract surgery than nondiabetic patients.

Entities:  

Mesh:

Year:  2006        PMID: 16857507     DOI: 10.1016/j.jcrs.2006.01.100

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  16 in total

1.  A prospective evaluation of posterior capsule opacification in eyes with diabetes mellitus: a case-control study.

Authors:  M R Praveen; A R Vasavada; G D Shah; A R Shah; B M Khamar; K H Dave
Journal:  Eye (Lond)       Date:  2014-03-28       Impact factor: 3.775

Review 2.  Cataract Surgery Considerations for Diabetic Patients.

Authors:  Jonathan A Go; Christina A Mamalis; Sumitra S Khandelwal
Journal:  Curr Diab Rep       Date:  2021-12-30       Impact factor: 4.810

3.  Long-term outcome of cataract surgery in patients with idiopathic hypoparathyroidism and its relationship with their calcemic status.

Authors:  Soma Saha; Shiva Prasad Gantyala; Sameer Aggarwal; Vishnubhatla Sreenivas; Radhika Tandon; Ravinder Goswami
Journal:  J Bone Miner Metab       Date:  2016-07-27       Impact factor: 2.626

4.  Echistatin prevents posterior capsule opacification in diabetic rabbit model via integrin linked kinase signaling pathway.

Authors:  Fengbin Lin; Yingying Chen; Hao Liang; Shaojian Tan
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

Review 5.  Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.

Authors:  Winfried M Amoaku; Faruque Ghanchi; Clare Bailey; Sanjiv Banerjee; Somnath Banerjee; Louise Downey; Richard Gale; Robin Hamilton; Kamlesh Khunti; Esther Posner; Fahd Quhill; Stephen Robinson; Roopa Setty; Dawn Sim; Deepali Varma; Hemal Mehta
Journal:  Eye (Lond)       Date:  2020-06       Impact factor: 3.775

6.  Posterior capsule opacification and neovascularization treated with intravitreal bevacizumab and Nd:YAG capsulotomy.

Authors:  Grimelda Yuriana Sánchez-Castro; Alejandra Hitos-Fájer; Erick Mendoza-Schuster; Raul Velez-Montoya; Cecilio Francisco Velasco-Barona
Journal:  Clin Ophthalmol       Date:  2008-09

7.  Apoptosis of lens epithelial cells induced by high concentration of glucose is associated with a decrease in caveolin-1 levels.

Authors:  Zhiyong Zhang; Ke Yao; Chongfei Jin
Journal:  Mol Vis       Date:  2009-09-30       Impact factor: 2.367

Review 8.  Posterior Capsule Opacification: A Review of Experimental Studies.

Authors:  Joanna Konopińska; Maryla Młynarczyk; Diana Anna Dmuchowska; Iwona Obuchowska
Journal:  J Clin Med       Date:  2021-06-27       Impact factor: 4.241

9.  Cataracts in diabetic patients: a review article.

Authors:  Mohammad-Ali Javadi; Siamak Zarei-Ghanavati
Journal:  J Ophthalmic Vis Res       Date:  2008-01

10.  Post-operative capsular opacification: a review.

Authors:  Shetal M Raj; Abhay R Vasavada; S R Kaid Johar; Vaishali A Vasavada; Viraj A Vasavada
Journal:  Int J Biomed Sci       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.